Singapore markets open in 8 hours 39 minutes

Xbrane Biopharma AB (7XB.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
0.1922+0.0008 (+0.42%)
As of 05:00PM CET. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
189,148
57,618
10,709
7,092
Cost of revenue
140,684
0
0
0
Gross profit
48,464
57,618
10,709
7,092
Operating expenses
Research development
286,345
199,648
160,619
197,284
Selling general and administrative
42,508
31,538
31,395
26,505
Total operating expenses
325,582
210,272
187,166
223,738
Operating income or loss
-277,118
-152,654
-176,457
-216,646
Interest expense
-
2,583
2,636
691
Income before tax
-284,719
-168,513
-183,226
-218,126
Income tax expense
0
0
0
0
Income from continuing operations
-284,719
-168,513
-183,226
-218,126
Net income
-291,371
-172,513
-188,376
-226,026
Net income available to common shareholders
-291,371
-172,513
-188,376
-226,026
Basic EPS
-10.44
-6.75
-7.98
-12.48
Diluted EPS
-10.44
-6.75
-7.98
-12.48
Basic average shares
27,993
25,570
23,593
18,113
Diluted average shares
27,993
25,570
23,593
18,113